2395.T Stock: Shin Nippon Biomedical Laboratories, Ltd. Stock Price, Analysis & Insights
Get live 2395.T stock price $1085.00, comprehensive Shin Nippon Biomedical Laboratories, Ltd. stock analysis, charts, news, and expert forecast. Real-time 2395.T stock data and investment insights.
Loading chart data...
Shin Nippon Biomedical Laboratories, Ltd. (2395.T) Overview
Shin Nippon Biomedical Laboratories, Ltd. (2395.T) is a publicly traded company in the Healthcare sector , specifically within the Medical - Diagnostics & Research industry . As of the latest trading session, 2395.T trades at $1085.00 with a market capitalization of 45.17B . Over the past 52 weeks, 2395.T has traded between $1067.00 and $2005.00 , with the current price positioned at approximat...
Key Takeaways
- Operates in the Healthcare sector (Medical - Diagnostics & Research)
- Market cap: 45.17B
- Current price: $1085.00
- 52-week range: $1067.00 - $2005.00
- P/E ratio: 9.89
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Shin Nippon Biomedical Laboratories, Ltd. operates as a global contract research organization (CRO), delivering comprehensive drug discovery and development services both in Japan and internationally. Its preclinical offerings encompass a wide array ...
Company Information
- CEO
- Ryoichi Nagata
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Employees
- 1457
Contact Information
- Website
- https://www.snbl.co.jp
- Address
- St. Luke’s Tower
- Country
- JP
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 9.9)
✓ Lower volatility stock (Beta: -0.25) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Shin Nippon Biomedical Laboratories, Ltd. shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Shin Nippon Biomedical Laboratories, Ltd.
- ⚠Investors should consider how Shin Nippon Biomedical Laboratories, Ltd. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
45.17B
P/E Ratio (TTM)
9.89
Beta
-0.25
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare 2395.T with peer companies:
- Price
- $485.00-0.21% (1D)
- Market cap
- 51.63B
- Price
- $3,510.00+1.89% (1D)
- Market cap
- 78.39B
- Price
- $1,902.00-0.78% (1D)
- Market cap
- 71.47B
- Price
- $1,554.00-0.26% (1D)
- Market cap
- 75.18B
- Price
- $1,178.00+0.86% (1D)
- Market cap
- 47.12B
- Price
- $485.00-0.21% (1D)
- Market cap
- 33.57B
- Price
- $2,417.00+0.21% (1D)
- Market cap
- 68.63B
- Price
- $2,170.00-0.46% (1D)
- Market cap
- 52.51B
- Price
- $351.00+2.03% (1D)
- Market cap
- 34.43B
- Price
- $2,063.00-0.96% (1D)
- Market cap
- 73.42B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
43/100 ⭐⭐⭐
- Overall
- -1.0%
- NYSE
- -1.6%
- NASDAQ
- -0.4%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +0.3% | +1.3% | +1.9% | 19.8 | 83/100⭐⭐⭐⭐⭐ |
| Technology | +0.8% | +1.1% | +3.0% | 52.0 | 76/100⭐⭐⭐⭐⭐ |
| Basic Materials | +0.8% | +0.3% | +1.9% | 27.9 | 69/100⭐⭐⭐⭐ |
| Industrials | -0.3% | -0.9% | +2.7% | 43.0 | 64/100⭐⭐⭐⭐ |
| Communication Services | -0.8% | -1.3% | +0.4% | 21.9 | 48/100⭐⭐⭐ |
| Consumer Defensive | +0.6% | +1.6% | -2.5% | 31.2 | 44/100⭐⭐⭐ |
| Healthcare | -1.0% | -2.0% | +1.5% | 30.5 | 43/100⭐⭐⭐ |
| Real Estate | +0.5% | -1.1% | -0.0% | 50.0 | 33/100⭐⭐ |
| Energy | +0.5% | -3.6% | -0.0% | 35.9 | 31/100⭐⭐ |
| Utilities | +2.0% | -1.3% | -5.1% | 26.1 | 31/100⭐⭐ |
| Consumer Cyclical | -0.3% | +0.3% | -0.2% | 55.8 | 28/100⭐⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-06-13.